A novel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesis.
Angiogenesis is a hallmark of tumor development and metastasis and now a validated target for cancer treatment. We previously reported that a novel dimer peptide (apoEdp) derived from the receptor binding region of human apolipoprotein E (apoE) inhibits virus-induced angiogenesis. However, its role...
Guardado en:
Autores principales: | Partha S Bhattacharjee, Tashfin S Huq, Tarun K Mandal, Richard A Graves, Syed Muniruzzaman, Christian Clement, Harris E McFerrin, James M Hill |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0435529784594d09a8ef39cc2d5295bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
How the water-soluble hemicarcerand incarcerates guests at room temperature decoded with modular simulations
por: Katherine G. McFerrin, et al.
Publicado: (2021) -
Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis
por: Getz GS, et al.
Publicado: (2011) -
Self-Assembling Peptide-Based Hydrogels in Angiogenesis
por: Han C, et al.
Publicado: (2020) -
Peptide-coated gold nanoparticles for modulation of angiogenesis in vivo
por: Roma-Rodrigues C, et al.
Publicado: (2016) -
Arresten, a collagen-derived angiogenesis inhibitor, suppresses invasion of squamous cell carcinoma.
por: Mari Aikio, et al.
Publicado: (2012)